Caring for a Patient With c-Diff

/ Samples / By

Module 07 Written Assignment – C-Diff

Module 07 Content

Your written assignment for this module should be a 1-2 page paper (not including title page and reference page) that describes the following:

You are caring for a patient with c-diff as part of your workload assignment. Discuss what c-diff is and how it is transmitted (how you can get it)?

What actions will you take as a nurse to protect yourself and the other patients on the unit when taking care of your patient?

You should include a minimum of 3 scholarly references. Include a title page, in-text citations, and a reference page in APA format.

Submit your completed assignment by following the directions linked below. Please check the Course Calendar for specific due dates.

caring for a patient with c-diff

Title: Managing Clostridioides difficile (C-Diff) in a Healthcare Setting

Introduction Clostridioides difficile (C-diff) is a bacterium that causes severe diarrhea and colitis, posing significant challenges in healthcare settings. This paper discusses the nature of C-diff, its transmission mechanisms, and nursing interventions to protect oneself and other patients.

Understanding C-Diff Clostridioides difficile, commonly referred to as C-diff, is a gram-positive, spore-forming bacterium. It is a leading cause of healthcare-associated infections, particularly in patients with prolonged antibiotic use, which disrupts normal gut flora and allows C-diff to proliferate. Symptoms of C-diff infection (CDI) range from mild diarrhea to life-threatening inflammation of the colon (Leffler & Lamont, 2015).

Transmission of C-Diff C-diff is primarily transmitted via the fecal-oral route. The spores can survive on surfaces for extended periods and are resistant to many disinfectants. Transmission occurs when a person touches a contaminated surface or object and then touches their mouth or mucous membranes (Dubberke & Olsen, 2012). In healthcare settings, the spread is facilitated by contact with contaminated equipment, surfaces, or hands of healthcare personnel who have not practiced adequate hand hygiene.

Nursing Actions to Protect Yourself and Others As a nurse, taking comprehensive precautions is crucial to prevent the spread of C-diff. The following actions are essential:

  1. Hand Hygiene: Rigorous handwashing with soap and water, not just alcohol-based hand sanitizers, is critical because C-diff spores are resistant to alcohol (McDonald et al., 2018).
  2. Personal Protective Equipment (PPE): Utilize gloves and gowns when entering the patient’s room. Dispose of these items properly before exiting to prevent cross-contamination (Centers for Disease Control and Prevention [CDC], 2019).
  3. Environmental Cleaning: Ensure thorough cleaning and disinfection of the patient’s room and equipment with sporicidal agents. Daily cleaning protocols and terminal cleaning after patient discharge are necessary to eradicate spores (Gerding et al., 2015).
  4. Patient Isolation: Implement contact precautions, placing the patient in a private room or cohorting with other C-diff patients to limit the spread to other patients (CDC, 2019).
  5. Antibiotic Stewardship: Advocate for judicious use of antibiotics to prevent disruption of normal gut flora, which can lead to CDI. Collaborate with healthcare providers to ensure antibiotics are used appropriately (Drekonja et al., 2015).

Conclusion Managing C-diff in a healthcare setting requires vigilant adherence to infection control protocols. By understanding the transmission mechanisms and implementing rigorous hand hygiene, PPE use, environmental cleaning, patient isolation, and antibiotic stewardship, nurses can effectively protect themselves and other patients from this challenging infection.

References

Centers for Disease Control and Prevention. (2019). Healthcare-associated Infections (HAI) Clostridioides difficile Infection (CDI). Retrieved from https://www.cdc.gov/hai/organisms/cdiff/cdiff_infect.html

Dubberke, E. R., & Olsen, M. A. (2012). Burden of Clostridium difficile on the healthcare system. Clinical Infectious Diseases, 55(suppl_2), S88-S92.

Drekonja, D. M., Amundson, W. H., DeCarolis, D. D., Kuskowski, M. A., & Johnson, J. R. (2015). Antimicrobial use and risk for recurrent Clostridium difficile infection. American Journal of Infection Control, 43(4), 442-447.

Gerding, D. N., Muto, C. A., & Owens, R. C. (2015). Measures to control and prevent Clostridium difficile infection. Clinical Infectious Diseases, 61(suppl_2), S29-S50.

Leffler, D. A., & Lamont, J. T. (2015). Clostridium difficile infection. New England Journal of Medicine, 372(16), 1539-1548.

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., … & Wilcox, M. H. (2018). Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 66(7), 987-994.

Scroll to Top